SNDL Inc. Common Shares (SNDL)
Stock · NASDAQ · Health Care
$1.26as of 10/16/2026
Price chart
Active signals
SNDL Signal Track Record
How signals performed across all stocks →What SNDL's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume SpikeActive now | 35 | -7.9% | 31% | September 9, 2026 |
| Bollinger Band Breakout | 23 | -8.4% | 26% | August 20, 2026 |
| Bollinger Band Breakdown | 21 | -1.1% | 38% | September 30, 2026 |
| 200-Day Moving Average TouchActive now | 8 | -4.8% | 38% | December 11, 2025 |
| Any 20-session window (baseline) | -3.0% | 39% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SNDL
SNDL Inc. engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada and internationally. It operates through four segments: Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments. The company engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sale of wines, beers, and spirits through liquor stores under th…
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Employees
- 2,751
- Website
- www.sndl.com/
Fundamentals
- 1-day range
- $1.13$1.23
- Market cap
- $312.36M
- P/E (trailing)
- —
- P/E (forward)
- 40.33
- EPS (trailing)
- $-0.08
- Dividend yield
- —
- Beta
- 1.00
- Avg. volume
- 1.55M
Forecasts
2 analyst ratings
SNDL Inc. Common Shares Competitors
Chosen by industry and closest market cap.
- SNDLSNDL Inc. Common Shares$1.25▲ 3.31%Market cap $312.36MP/E —$1.13$2.57
- USNAUSANA Health Sciences Inc. Common Stock$15.54▲ 1.04%Market cap $274.91MP/E 32.28$12.57$23.59
- OBIOOrchestra BioMed Holdings Inc. Ordinary Shares$5.45▼ 5.05%Market cap $248.50MP/E —$3.1$6.5
- NAGENiagen Bioscience Inc. Common Stock$2.49▼ 3.49%Market cap $240.54MP/E 12.74$2.51$7.95
- CGCCanopy Growth Corporation Common Shares$0.713▼ 3.13%Market cap $400.49MP/E —$0.995$3.28
- ACBAurora Cannabis Inc. Common Shares$3.99▼ 2.68%Market cap $184.63MP/E —$3.59$8.75
- MDWDMediWound Ltd. Ordinary Shares$11.85▼ 2.95%Market cap $183.44MP/E —$11.9$20.03
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SNDL SNDL Inc. Common Shares | $312.36M | — | $1.25 | ▲ 3.31% | $1.13$2.57 |
| USNA USANA Health Sciences Inc. Common Stock | $274.91M | 32.28 | $15.54 | ▲ 1.04% | $12.57$23.59 |
| OBIO Orchestra BioMed Holdings Inc. Ordinary Shares | $248.50M | — | $5.45 | ▼ 5.05% | $3.1$6.5 |
| NAGE Niagen Bioscience Inc. Common Stock | $240.54M | 12.74 | $2.49 | ▼ 3.49% | $2.51$7.95 |
| CGC Canopy Growth Corporation Common Shares | $400.49M | — | $0.713 | ▼ 3.13% | $0.995$3.28 |
| ACB Aurora Cannabis Inc. Common Shares | $184.63M | — | $3.99 | ▼ 2.68% | $3.59$8.75 |
| MDWD MediWound Ltd. Ordinary Shares | $183.44M | — | $11.85 | ▼ 2.95% | $11.9$20.03 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Institutional Ownership
March 31, 2026
- Total shares held
- 56.20M
- Total value held
- $72.69M
- Institutional holders
- 107
- Unknown11.41M
- Unknown8.76M
- Unknown5.51M
- Unknown3.85M
- Unknown3.51M
- Unknown3.00M
- Unknown2.86M
- Unknown2.24M
- Unknown1.30M
- Unknown1.18M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
SNDL: DEA Judge Pauses Marijuana Rescheduling Hearing
A federal judge has temporarily paused the hearing on rescheduling marijuana. Opponents cited a government report that points to gaps in the federal process. The delay adds uncertainty to potential policy changes that could affect companies like SNDL. The stock remains near its recent support level.
SNDL: DEA Judge Pauses Marijuana Rescheduling Hearing. A federal judge has temporarily paused the hearing on rescheduling marijuana. Opponents cited a government report that points to gaps in the federal process. The delay adds uncertainty to potential policy changes that could affect companies like SNDL. The stock remains near its recent support level.